Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study on the Effects of Enpatoran for Patients with Dermatomyositis and Polymyositis
CzechiaStudy on Metformin for Delaying Progression in Non-Active Progressive Multiple Sclerosis Patients
BelgiumStudy on the Effects of Guselkumab on Memory T-Cells in Psoriasis Patients
DenmarkStudy on Ketotifen Eye Drops for Treating Seasonal Allergic Conjunctivitis in Patients
ItalyContinued Treatment Study for Patients with Myelofibrosis, Post-Lung Transplant BOS, or Chronic Graft-Versus-Host Disease Using Itacitinib
AustriaStudy on the Effects of GLPG3667 for Adults with Dermatomyositis
BelgiumStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
AustriaStudy on Long-Term Safety of Eplontersen for Adults with Transthyretin-Mediated Amyloid Cardiomyopathy
AustriaStudy on the Effectiveness and Safety of BP1.7881 for Adults with Moderate-to-Severe Atopic Dermatitis
FranceLong-Term Follow-Up Study of Imlifidase in Highly Sensitized Kidney Transplant Patients
AustriaStudy on Dexamethasone Film for Patients with Acute Allergic Reactions
SwedenThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
